Related Experiment Video
Updated: May 20, 2025

Detection of Post-Replicative Gaps Accumulation and Repair in Human Cells Using the DNA Fiber Assay
Published on: February 3, 2022
MRN-CtIP, EXO1, and DNA2-WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand
Isabelle M Seppa1, Ilaria Ceppi2, Mithila Tennakoon1
1Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri 63110, USA.
Abstract:
Single-stranded DNA (ssDNA) gaps impact genome stability and PARP inhibitor (PARPi) sensitivity, especially in BRCA1/2-deficient tumors. Using single-molecule DNA fiber analysis, electron microscopy, and biochemical methods, we found that MRN, CtIP, EXO1, and DNA2-WRN/BLM resect ssDNA gaps through a mechanism different from their actions at DNA ends. MRN resects ssDNA gaps in the 3'-to-5' direction using its pCtIP-stimulated exonuclease activity. Unlike at DNA ends, MRN does not use its endonucleolytic activity to cleave the 5'-terminated strand flanking the gap or the ssDNA. EXO1 and DNA2-WRN/BLM specifically resect the 5' end of the gap independent of MRN-CtIP. This resection process alters ssDNA gap repair kinetics in BRCA1-proficient and -deficient cells. In BRCA1-deficient cells treated with PARPis, excessive resection results in larger ssDNA gaps, hindering their repair and leading to DNA breaks in subsequent cell cycle stages due to ssDNA gaps colliding with DNA replication forks. These findings broaden our understanding of the role of human nucleases in DNA metabolism and have significant implications for defining the mechanisms driving PARPi sensitivity in BRCA-deficient tumors.
Insights
Researchers discovered how nucleases process single-stranded DNA (ssDNA) gaps, impacting genome stability. This mechanism explains PARP inhibitor (PARPi) sensitivity in BRCA-deficient cancers.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Single-stranded DNA (ssDNA) gaps are critical in maintaining genome stability.
- ssDNA gaps influence the sensitivity of BRCA1/2-deficient tumors to PARP inhibitors (PARPi).
Purpose of the Study:
- To elucidate the distinct mechanisms by which nucleases resect ssDNA gaps.
- To understand how ssDNA gap resection impacts DNA repair and PARPi sensitivity in BRCA-deficient cells.
Main Methods:
- Single-molecule DNA fiber analysis
- Electron microscopy
- Biochemical assays
Main Results:
- MRN, CtIP, EXO1, and DNA2-WRN/BLM enzymes resect ssDNA gaps via a novel mechanism distinct from DNA end resection.
- MRN utilizes its 3'-to-5' exonuclease activity, stimulated by CtIP, for ssDNA gap resection.
- EXO1 and DNA2-WRN/BLM independently resect the 5' end of ssDNA gaps.
- Excessive resection in BRCA1-deficient cells treated with PARPi leads to larger ssDNA gaps, impaired repair, and subsequent DNA breaks.
Conclusions:
- The study reveals specific nucleases and pathways involved in ssDNA gap processing.
- Altered ssDNA gap resection contributes to DNA breaks and PARPi sensitivity in BRCA-deficient tumors.
- Findings enhance understanding of DNA metabolism and PARPi therapeutic strategies.
Related Concept Videos
Homologous Recombination
Long-patch Base Excision Repair
Restarting Stalled Replication Forks
Base Excision Repair
The first step of...
Mismatch Repair
DNA Damage can Stall the Cell Cycle

